Reply  by Barillà, Francesco
assessment of only non–Q-wave MIs, which dates from a period
when the non–Q wave MI was assumed to be a valid subset with
unique characteristics. It is to be hoped that this misconception has
been permanently put to rest and, further, that investigations of
outcome after MI will avoid the egregious error of combining
random mixtures of first and subsequent infarcts.
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Does Flow Reserve Match Contractility?
I have read with great interest the report by Barilla` et al. (1). The
data reported are intriguing because, to the best of my knowledge,
this is the first report indicating that the restoration of regional
contractility during low dose dobutamine administration may
occur despite different perfusion patterns, depending on the
presence or absence of collateral filling.
Let me raise an issue not addressed in the Discussion of Barilla`’s
article. I definitely agree with Bonow (2) that the increase in flow
in patients with collateral filling is expected, because the drop of
pressure beyond the fixed obstruction can increase the flow, despite
the coronary driving pressure’s being unchanged. The no-
measurable-flow response in patients without collateral channels
can also be expected. In fact, why should the flow increase through
a stenosis or an occlusion? Irrespective of flow regimen, the authors
(1) noted an amelioration in contractility of dysfunctional myocar-
dium—one that was still present at 2-methoxy-isobutyl-isonitrile
(MIBI) administration and during the time allowed for it to
distribute to the myocardium (i.e., up to 8 min), I presume,
because no mention was ever made to subsequent deterioration of
wall motion. This is an astonishingly long time, which would more
appropriately define the response to low dose dobutamine of
stunned myocardium (but this was not the case, as indicated by the
low sestamibi uptake). It seems inconceivable that such a pro-
longed increase in contractility may occur in the absence of an
adequate increase in blood flow, the situation being absolutely
different from the postextrasystolic potentiation of contractility,
when myocytes burn their energy stores all in one go. By contrast,
the increase in contractility of ischemic but viable myocardium at
low dose dobutamine is a short-lived phenomenon: it may begin at
very low dosage (as low as 2.5 mg/kg body weight per min, in our
experience) and usually fades away at 10 mg/kg per min, seldom at
20 mg/kg per min. In patients with very severe coronary stenosis or
coronary occlusion without collateral blood filling, a biphasic
response to dobutamine should be expected at a dosage even lower
than that at which the authors injected technetium-99m sestamibi.
Given this, as well as the notion of the ischemic cascade (3,4), I
make the point that Barilla` et al. (1) described an intermediate
phase of the biphasic response phenomenon—that is, the time
when the flow reserve is exhausted, but wall contractility has not
yet deteriorated in response to forthcoming or ongoing ischemia,
or both. I suggest that this possibility is whispered to the reader.
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We are grateful to Dr. Barletta for his comments. Obviously, the
findings we have reported constitute an intermediate step of a
biphasic response phenomenon, as stated by Dr. Barletta. How-
ever, a 5-min step protocol for low dose dobutamine echocardi-
ography is common (1,2), and a biphasic response (i.e., wall
motion improvement followed by worsening) is rarely observed at
low doses of 5 to 10 mg/kg body weight per min (3). Nevertheless,
no change in wall motion and thickening occurred during the
3 min after tracer injection, even when we used 10 mg/kg per min
of dobutamine.
We also wish to emphasize that our study was not intended to
describe the behavior of inotropic contractile reserve during low
dose dobutamine infusion, but it was aimed at investigating the
pathophysiologic and clinical implications of the presumed mis-
match between perfusion and contractility in areas with severely
hypoperfused viable myocardium.
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Preconditioning, Collateral
Recruitment and Adenosine
We read with interest the recent article by Billinger et al. (1). It
shows that the myocardial adaptation to repetitive ischemia during
percutaneous transluminal coronary angioplasty (PTCA) is par-
tially due to collateral recruitment, which accounted for 30% of the
observed variation in intracoronary ST segment shifts and is
mainly related to ischemic preconditioning. These findings are in
agreement with several previous reports by our group (2–4) and
others (5,6) using the PTCA model of ischemic preconditioning.
However, it is surprising that, by contrast to extensive evidence
supporting a prominent role for adenosine and its receptors in
mediating the cardioprotective effects of preconditioning in both
experimental (7–9) and clinical (10–12) studies, Billinger et al. (1)
failed to show pharmacologic preconditioning with adenosine
during PTCA. However, the authors measured ST segment shifts
only 1 min after the beginning of balloon inflation, a period
insufficient for the achievement of the full evolution of ST segment
shift, as previously demonstrated (6). Furthermore, for the assess-
ment of myocardial ischemia severity, Billinger et al. (1) adjusted
ST segment amplitude with QRS amplitude. This adjusted index
of myocardial ischemia remains to be validated in the experimental
setting of repeated balloon inflations, especially because during
PTCA there are changes in the QRS amplitude, which are variably
correlated (r2 5 0.29 to 0.81) with those of ST segment shifts (13).
Surprisingly, unadjusted ST segment changes, which have been
experimentally validated (14,15), are not provided. Thus, it would
be interesting to know whether the results obtained by Billinger et
al. (1) regarding the effects of adenosine on preconditioning are
confirmed when absolute ST segment changes measured after
2 min of balloon inflation are utilized. Similar considerations apply
to the relation between changes of ST segment shift and those of
collateral flow index. This would make it possible to compare their
results with those of several previous published studies on this
topic (2–6,10–12,16).
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We thank Tomai and colleagues for their comments on our recent
investigation (1). Their reading of our report is different from the
wording as well as from the intended meaning, which was that
even in patients with only a few collateral channels, their recruit-
ment, as an adaptive mechanism to repetitive ischemia does occur.
Our study did not show that the development of ischemic
tolerance “is mainly related to ischemic preconditioning.” If col-
lateral recruitment was observed to account for 30% of the
variation in electrocardiographic ST segment shifts, the quoted
conclusion certainly cannot be drawn. It can only be suggested (as
we did in our conclusion) that ischemic preconditioning may be a
relevant factor in the development of tolerance to ischemia. It is
correct that we could not reproduce recent data from the published
reports on the effectiveness of adenosine as “preconditioner.” This
was the case despite the fact that we used a study protocol and
dosage of adenosine identical to that used by Leesar et al. in their
investigation (2). To call the three cited studies in humans on the
effect of adenosine “extensive evidence” appears slightly exagger-
ated to us.
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